Implantable Material Patterned Surface Enhances Endothelialization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional implantable medical devices made from materials like titanium, polytetrafluoroethylene, and silicone elicit inadequate tissue integration and often provoke significant inflammatory responses, leading to fibrous encapsulation and adverse effects.

Innovation Solution

The development of an implantable biocompatible material with a patterned array of geometric physiologically functional features, created through vacuum deposition techniques, which enhances endothelial cell binding, proliferation, and migration, thereby promoting complete device integration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional materials (titanium, polytetrafluoroethylene, silicone) are used for implantable devices, then the devices have strength and physiologically inert characteristics, but tissue integration is slow and inadequate and inflammatory responses occur

Engineering Contradiction:
Improvetissue integrationVSAvoidinflammatory response
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by creating a patterned surface with alternating hydrophobic and hydrophilic regions. The hydrophobic regions (e.g., PTFE) provide blood compatibility and reduce thrombogenicity, while the hydrophilic regions (e.g., titanium oxide) promote endothelial cell adhesion and proliferation. This spatial differentiation of surface properties resolves the contradiction between needing tissue integration and avoiding inflammatory responses.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs composite materials by combining multiple materials with different surface properties in a single implantable device. Specifically, it integrates PTFE (polytetrafluoroethylene) with titanium or stainless steel substrates, creating a composite structure where the PTFE provides chemical inertness and blood compatibility, while the metal substrate provides structural strength and can be surface-modified to promote endothelialization through vacuum deposition techniques.

Inventive Principle:
Principle #40Composite materials

2Reliability

If materials are modified to promote endothelial cell adhesion, then endothelial proliferation is enhanced, but the devices become more thrombogenic

Engineering Contradiction:
Improveendothelial cell adhesionVSAvoidthrombogenicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent resolves this contradiction by creating locally differentiated surface regions. Hydrophilic regions with specific surface energies promote endothelial cell adhesion and proliferation, while hydrophobic PTFE regions reduce protein adsorption and thrombus formation. The patterned arrangement ensures that thrombogenic and anti-thrombogenic properties are spatially separated, allowing the device to simultaneously promote endothelialization and reduce thrombogenicity.

Inventive Principle:
Principle #3Local quality

3Reliability

If vacuum deposited layers with patterned arrays are created, then endothelialization is accelerated and tissue integration is enhanced, but the manufacturing process becomes more complex

Engineering Contradiction:
ImproveendothelializationVSAvoidmanufacturing process
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-pattern the implantable device surface with alternating hydrophobic and hydrophilic regions before implantation. The vacuum deposition process deposits metal layers (titanium, stainless steel) with controlled patterns, and subsequent surface treatment (e.g., oxidation, plasma processing) creates the desired hydrophobic-hydrophilic pattern. This preliminary structuring accelerates endothelialization when the device is implanted, while the patterning can be integrated into existing manufacturing workflows.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs parameter changes by controlling surface energy characteristics through vacuum deposition parameters (deposition rate, temperature, pressure) and post-treatment conditions (oxidation time, plasma power). By adjusting these parameters, the surface can be tuned to exhibit specific hydrophobic or hydrophilic properties in different regions, enabling control over endothelial cell behavior without fundamentally changing the manufacturing process flow.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The implementation of this solution significantly accelerates endothelialization of implantable devices, reducing inflammatory responses and enhancing the healing process, ultimately leading to improved integration and functionality of the devices within the body.

Implementation Method 1

one or more vacuum deposited layers of biocompatible materials deposited upon a biocompatible base material

Methodology Applied
Scientific EffectVacuum deposition: Physical Vapour Deposition

Data Source

PatentEP2707044B1Implantable materials having engineered surfaces and method of making same
Publication Date: 2025.06.04 VACTRONIX SCIENTIFIC LLC
  • EP2707044B1 patent drawingFigure 1~4
  • EP2707044B1 patent drawingFigure 5~6A
  • EP2707044B1 patent drawingFigure 6B~6C

AI summary

An implantable biocompatible material includes one or more vacuum deposited layers of biocompatible materials deposited upon a biocompatible base material. At least a top most vacuum deposited layer includes a homogeneous molecular pattern of distribution along the surface thereof and comprises a patterned array of geometric physiologically functional features.